Aspira Women's Health
ARPA-H Awards $110M to Commercial, Academic Teams Tackling Women's Health
The awardees included several diagnostics firms, among them Aspira Women's Health, which received $10 million for development of its EndoMDx test.
People in the News at Genomenon, Mainz Biomed, Waters, AMP, SeqOne Genomics, More
Executive appointments, promotions, and departures in omics and molecular diagnostics for the week of Oct. 23, 2023
Aspira Women's Health Licenses Dana-Farber microRNA Signature; Firm Executes Reverse Stock Split
Aspira Women's Health has been evaluating Dana-Farber's microRNA technology for ovarian cancer detection since early 2021.
Aspira Women's Health Prices $9M Public Offering
The company is offering 12 million shares of common stock along with warrants to purchase 12 million shares.
Earnings Roundup: DermTech, 908 Devices, OraSure, Codex DNA, Aspira, IsoPlexis, Epigenomics
DermTech, 908 Devices, OraSure Technologies, Codex DNA, Aspira Women's Health, and Epigenomics reported quarterly financial results this week.